Search

Willie J. Daniel Jr.

Examiner (ID: 12204, Phone: (571)272-7907 , Office: P/2462 )

Most Active Art Unit
2462
Art Unit(s)
2462, 2465, 2641, 2617, 2686
Total Applications
889
Issued Applications
433
Pending Applications
99
Abandoned Applications
374

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16627356 [patent_doc_number] => 20210046009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/086702 [patent_app_country] => US [patent_app_date] => 2020-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32739 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086702 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/086702
PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS Nov 1, 2020 Abandoned
Array ( [id] => 16627340 [patent_doc_number] => 20210045993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => COSMETIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/085166 [patent_app_country] => US [patent_app_date] => 2020-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085166 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/085166
COSMETIC COMPOSITIONS Oct 29, 2020 Abandoned
Array ( [id] => 18056330 [patent_doc_number] => 20220387416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => ATROPINE-SCOPOLAMINE WITH ENHANCED STABILITY [patent_app_type] => utility [patent_app_number] => 17/755055 [patent_app_country] => US [patent_app_date] => 2020-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8183 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755055 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/755055
ATROPINE-SCOPOLAMINE WITH ENHANCED STABILITY Oct 25, 2020 Pending
Array ( [id] => 16776498 [patent_doc_number] => 20210113575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/075447 [patent_app_country] => US [patent_app_date] => 2020-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27482 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075447 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/075447
Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same Oct 19, 2020 Issued
Array ( [id] => 16776382 [patent_doc_number] => 20210113459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => CHEWABLE GEL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/073068 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6520 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073068 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/073068
CHEWABLE GEL FORMULATIONS Oct 15, 2020 Abandoned
Array ( [id] => 16596731 [patent_doc_number] => 20210023262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => COMPOSITION AND DRESSING WITH NITRIC OXIDE [patent_app_type] => utility [patent_app_number] => 17/068297 [patent_app_country] => US [patent_app_date] => 2020-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10388 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17068297 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/068297
COMPOSITION AND DRESSING WITH NITRIC OXIDE Oct 11, 2020 Abandoned
Array ( [id] => 18970529 [patent_doc_number] => 20240050621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => OCULAR SEALANTS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/766445 [patent_app_country] => US [patent_app_date] => 2020-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11748 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766445 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/766445
OCULAR SEALANTS AND METHODS OF USING THE SAME Oct 7, 2020 Pending
Array ( [id] => 16762580 [patent_doc_number] => 20210108161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => SANITISING COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/063325 [patent_app_country] => US [patent_app_date] => 2020-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8030 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063325 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/063325
SANITISING COMPOSITION Oct 4, 2020 Abandoned
Array ( [id] => 19402035 [patent_doc_number] => 20240285546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE [patent_app_type] => utility [patent_app_number] => 17/786217 [patent_app_country] => US [patent_app_date] => 2020-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32399 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786217 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/786217
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE Oct 1, 2020 Pending
Array ( [id] => 18706732 [patent_doc_number] => 20230329304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => METABOLIC THERAPY OF CANCER [patent_app_type] => utility [patent_app_number] => 18/025229 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13720 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025229 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025229
METABOLIC THERAPY OF CANCER Sep 22, 2020 Pending
Array ( [id] => 17480493 [patent_doc_number] => 20220087997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => Oral Antagonist Compositions For Nicotine Burning Relief [patent_app_type] => utility [patent_app_number] => 17/028002 [patent_app_country] => US [patent_app_date] => 2020-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028002 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/028002
Oral Antagonist Compositions For Nicotine Burning Relief Sep 21, 2020 Pending
Array ( [id] => 16539339 [patent_doc_number] => 20200405752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => ANTITUMOR AGENT, ANTITUMOR EFFECT ENHANCER, AND ANTITUMOR KIT [patent_app_type] => utility [patent_app_number] => 17/018413 [patent_app_country] => US [patent_app_date] => 2020-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12252 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018413 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/018413
ANTITUMOR AGENT, ANTITUMOR EFFECT ENHANCER, AND ANTITUMOR KIT Sep 10, 2020 Pending
Array ( [id] => 16539252 [patent_doc_number] => 20200405665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-31 [patent_title] => METHODS FOR THE TREATMENT OF ROSACEA [patent_app_type] => utility [patent_app_number] => 17/016542 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016542 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/016542
METHODS FOR THE TREATMENT OF ROSACEA Sep 9, 2020 Abandoned
Array ( [id] => 16523689 [patent_doc_number] => 20200397769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => STABLE NIMODIPINE PARENTERAL FORMULATION [patent_app_type] => utility [patent_app_number] => 17/014276 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12509 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014276 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/014276
STABLE NIMODIPINE PARENTERAL FORMULATION Sep 7, 2020 Abandoned
Array ( [id] => 17843720 [patent_doc_number] => 11433062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Stable nimodipine parenteral formulation [patent_app_type] => utility [patent_app_number] => 17/011345 [patent_app_country] => US [patent_app_date] => 2020-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 11580 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011345 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/011345
Stable nimodipine parenteral formulation Sep 2, 2020 Issued
Array ( [id] => 17911425 [patent_doc_number] => 20220313820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => ULTRASOUND-ASSISTED DRUG DELIVERY CARRIER USING ULTRASOUND CONTRAST AGENT CONTAINING LIGAND CONJUGATED WITH DRUG THROUGH ESTER BOND [patent_app_type] => utility [patent_app_number] => 17/424485 [patent_app_country] => US [patent_app_date] => 2020-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424485 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/424485
ULTRASOUND-ASSISTED DRUG DELIVERY CARRIER USING ULTRASOUND CONTRAST AGENT CONTAINING LIGAND CONJUGATED WITH DRUG THROUGH ESTER BOND Aug 26, 2020 Pending
Array ( [id] => 17648403 [patent_doc_number] => 11351102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-07 [patent_title] => Plant actives and their anti-pollution effects thereof [patent_app_type] => utility [patent_app_number] => 17/003760 [patent_app_country] => US [patent_app_date] => 2020-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 8826 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003760 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/003760
Plant actives and their anti-pollution effects thereof Aug 25, 2020 Issued
Array ( [id] => 17944210 [patent_doc_number] => 20220331227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => MICROCAPSULE AND HAIR CARE COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/639385 [patent_app_country] => US [patent_app_date] => 2020-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639385 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/639385
Microcapsule and hair care composition Aug 24, 2020 Issued
Array ( [id] => 17897308 [patent_doc_number] => 20220306970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/632971 [patent_app_country] => US [patent_app_date] => 2020-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632971 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/632971
IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Aug 20, 2020 Pending
Array ( [id] => 16481588 [patent_doc_number] => 20200375188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => Compositions, Methods and Uses for Cleaning, Disinfecting and/or Sterilizing [patent_app_type] => utility [patent_app_number] => 16/994847 [patent_app_country] => US [patent_app_date] => 2020-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82402 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994847 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/994847
Compositions, methods and uses for cleaning, disinfecting and/or sterilizing Aug 16, 2020 Issued
Menu